RHON-KLINIKUM AG Reports Strong Q3 2026 Results with 8.3% Patient Increase and Higher Profit

RHON-KLINIKUM AG's Q3 2026 results show an 8.3% rise in patients treated, revenues of EUR 1,304 million, and improved profit, highlighting financial stability and investment in advanced medical technology.

DC Metrowire Staff
••Healthcare
RHON-KLINIKUM AG Reports Strong Q3 2026 Results with 8.3% Patient Increase and Higher Profit

RHON-KLINIKUM AG closed the first nine months of 2026 with strong earnings growth, reporting an 8.3% increase in patients treated and a rise in consolidated profit. The group treated 764,248 patients on an inpatient and outpatient basis from January to September 2026, up from 705,830 in the same period of 2025. Consolidated revenue reached EUR 1,303.8 million, exceeding the previous year's EUR 1,262.1 million, while EBITDA rose to EUR 83.9 million from EUR 71.8 million. Consolidated profit increased to EUR 32.7 million, compared with EUR 25.1 million in the prior-year period. The results matter because they demonstrate that RHON-KLINIKUM AG can expand patient volume and improve profitability despite a challenging healthcare policy environment and difficult economic conditions.

The profit increase was driven by higher capacity utilization at clinics and medical care centers, particularly in the outpatient sector, as well as a 3.25% billing surcharge on hospital services that is accounted for under "other income" through October 2026. This surcharge is intended to offset increases in personnel and non-personnel costs from previous years. The company's strong capital base, reflected in an equity ratio of 74.7%, provides a solid foundation for optimizing inpatient and outpatient care structures. Dr. Gunther K. WeiB, member of the Board of Management of RHON-KLINIKUM AG, stated: "Our successful third quarter shows that financial stability and medical excellence are inseparable, going hand in hand. Underlying this success is the tremendous trust our patients put in us. This sustainable basis is what allows us to continue making targeted investments in state-of-the-art medical technology and care offerings."

These investments include a state-of-the-art photon-counting computer tomograph at Universitatsklinikum Marburg, making RHON-KLINIKUM AG the only hospital group in Germany with four newest-generation units in operation. Additionally, a new hybrid operating theatre in Frankfurt (Oder) has expanded the hospital's treatment range and strengthened interdisciplinary structures, boosting care offerings in the Ostbrandenburg region. Dr. Stefan Stranz, also a member of the Board of Management, noted: "This forward-looking investment strategy ensures that we can continue to operate effectively in a market environment facing far-reaching and sweeping change. Thanks to our solid financial basis and our collaboration within the ASKLEPIOS Group network, we can take on and actively shape this transformation process from a position of strength."

For the full year 2026, RHON-KLINIKUM AG expects revenues of EUR 1.7 billion within a range of plus or minus 5%, and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates a moderate improvement in the number of cases and cost weights. However, the financial year will be significantly impacted by the unfolding legislation process, particularly the Hospital Reform Adjustment Act (KHAG) that entered into force on 15 April 2026 and the Statutory Health Insurance Contribution Rate Stabilisation Act (GKV-BStabG) adopted on 10 July 2026. While these laws aim to enhance quality and efficiency, they will put hospitals under greater financial pressure in the short term. The forecast is therefore subject to particular uncertainties, as it is not yet possible to reliably predict the overall impact of regulatory interference, hospital reform implementation, and further possible adjustments by the legislator. Ongoing global crises and negative economic impacts are also resulting in higher prices, supply bottlenecks, and general market volatility.

The Quarterly Statement for Q3 2026 is available on the Internet. RHON-KLINIKUM AG, a company of the ASKLEPIOS Group, operates five highly specialized maximum- and intermediate-care facilities and employs over 19,100 people. The original release is available on www.newmediawire.com, and more information about the company can be found at www.rhoen-klinikum-ag.com.

Blockchain Registration

QR Code for Blockchain Registration